Anna A. Dyachkova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anna A. Dyachkova has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- A.V. Udalova
Kirov Regional Children’s Clinical Hospital
1 shared publication - Aleksandr Sergeevich Sorokin
Plekhanov Russian University of Economics
1 shared publication - Alena D. Maklakova
National Research Mordovia State University
1 shared publication - Alla E. Lavrova
Privolzhsky Research Medical University
1 shared publication - Anastasia E. Tsaplenkova
National Research Mordovia State University
1 shared publication - Anna A. Usanova
Ogarev Mordovian State University
1 shared publication
Latest Publications
- 14 October 2026
- Published by Media Sphere Publishing Group in Journal of Respiratory Medicine
- Vol. 2 (3)
Dynamics of lung function in patients with cystic fibrosis living in the Volga Federal District in 2017 and 2023
Cystic fibrosis (CF) is a severe hereditary disease that leads to decreased lung function. Objective. To assess the dynamics of lung function changes in CF patients living in the Volga Federal District (VFD) regions based on data from the 2017 and 2023 registries. Material and methods. Spirometry data from 375 patients from the 2017 CF patient registry and 451 patients from the 2023 registry were analyzed. Results. The median FEV1 data in VFD patients was 76.8% of the predicted value in 2017 and significantly increased to 95.3% of the predicted value in 2018. in 2023 (p<0.001). In 2017, FEV1 values in patients with CF in the Volga Federal District were not significantly different from those in the Russian Federation (75.5% of the predicted value), while in 2023, they were significantly higher than in patients in other regions of Russia (81.1% of the predicted value), p<0.001. FEV1 values increased significantly in patients from the Nizhny Novgorod Region, Orenburg Region, Perm Krai, the Republic of Tatarstan, and the Chuvash Republic. The median FVC in patients with CF from the Volga Federal District in 2017 was 85.1% of the predicted value and significantly increased to 94.0% of the predicted value in 2023 (p<0.01). In 2017, the FVC indicators in patients with CF in the Volga Federal District did not differ significantly from those in patients in the Russian Federation (86.0% of the predicted value), and in 2023 they were significantly higher than in patients in other regions of Russia (91.0% of the predicted value), p=0.037. The FVC indicators in 2023, compared with 2017, significantly increased in patients in the Nizhny Novgorod Region (p<0.001), Orenburg Region (p<0.001), Perm Krai (p=0.021), the Republic of Tatarstan (p=0.043), and the Chuvash Republic (p=0.003). In patients in the Samara Region, the indicators remained stable (p=0.331). Conclusions. FEV1 and FVC values in CF patients in both the Volga Federal District and the Russian Federation increased significantly in 2023 compared to 2017. Patient data from Volga Federal District regions where specialized CF centers were established were more informative, and patients had higher lung function values.
- 14 October 2026
- Published by Media Sphere Publishing Group in Journal of Respiratory Medicine
- Vol. 2 (3)
Dynamics of lung function in patients with cystic fibrosis living in the Volga Federal District in 2017 and 2023
Cystic fibrosis (CF) is a severe hereditary disease that leads to decreased lung function. Objective. To assess the dynamics of lung function changes in CF patients living in the Volga Federal District (VFD) regions based on data from the 2017 and 2023 registries. Material and methods. Spirometry data from 375 patients from the 2017 CF patient registry and 451 patients from the 2023 registry were analyzed. Results. The median FEV1 data in VFD patients was 76.8% of the predicted value in 2017 and significantly increased to 95.3% of the predicted value in 2018. in 2023 (p<0.001). In 2017, FEV1 values in patients with CF in the Volga Federal District were not significantly different from those in the Russian Federation (75.5% of the predicted value), while in 2023, they were significantly higher than in patients in other regions of Russia (81.1% of the predicted value), p<0.001. FEV1 values increased significantly in patients from the Nizhny Novgorod Region, Orenburg Region, Perm Krai, the Republic of Tatarstan, and the Chuvash Republic. The median FVC in patients with CF from the Volga Federal District in 2017 was 85.1% of the predicted value and significantly increased to 94.0% of the predicted value in 2023 (p<0.01). In 2017, the FVC indicators in patients with CF in the Volga Federal District did not differ significantly from those in patients in the Russian Federation (86.0% of the predicted value), and in 2023 they were significantly higher than in patients in other regions of Russia (91.0% of the predicted value), p=0.037. The FVC indicators in 2023, compared with 2017, significantly increased in patients in the Nizhny Novgorod Region (p<0.001), Orenburg Region (p<0.001), Perm Krai (p=0.021), the Republic of Tatarstan (p=0.043), and the Chuvash Republic (p=0.003). In patients in the Samara Region, the indicators remained stable (p=0.331). Conclusions. FEV1 and FVC values in CF patients in both the Volga Federal District and the Russian Federation increased significantly in 2023 compared to 2017. Patient data from Volga Federal District regions where specialized CF centers were established were more informative, and patients had higher lung function values.
- Open Access
- 28 March 2026
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 1,p. 125-129
Adult Still's disease: a clinical case
The article describes a clinical case of adult Still's disease in a 34-year-old female patient. The disease was characterized by persistent fever, arthralgia, lymphadenopathy, hepatosplenomegaly, erythematous skin rashes, pharyngitis, and persistent leukocytosis. After a complex differential diagnosis with acute appendicitis, sepsis, psoriasis, acute respiratory viral infections, intestinal infections, lymphoproliferative and autoimmune systemic diseases, the final clinical diagnosis was "adult Still's disease." Treatment was prescribed with dexamethasone, pentoxifylline, acetylsalicylic acid, and omeprazole. The patient's condition improved with the resolution of fever, the disappearance of erythematous rashes, and the alleviation of arthralgia. The normalization of the main indicators of the general blood test and C-reactive protein was observed. This scientific article highlights the relevance of the problem of the complexity of early diagnosis of adult Still's disease in order to prevent its negative consequences.
- 28 March 2026
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 1,p. 125-129
Open AccessAdult Still's disease: a clinical case
The article describes a clinical case of adult Still's disease in a 34-year-old female patient. The disease was characterized by persistent fever, arthralgia, lymphadenopathy, hepatosplenomegaly, erythematous skin rashes, pharyngitis, and persistent leukocytosis. After a complex differential diagnosis with acute appendicitis, sepsis, psoriasis, acute respiratory viral infections, intestinal infections, lymphoproliferative and autoimmune systemic diseases, the final clinical diagnosis was "adult Still's disease." Treatment was prescribed with dexamethasone, pentoxifylline, acetylsalicylic acid, and omeprazole. The patient's condition improved with the resolution of fever, the disappearance of erythematous rashes, and the alleviation of arthralgia. The normalization of the main indicators of the general blood test and C-reactive protein was observed. This scientific article highlights the relevance of the problem of the complexity of early diagnosis of adult Still's disease in order to prevent its negative consequences.
- Open Access
- 16 February 2026
- Published by Vitebsk State Medical University in Vestnik of Vitebsk State Medical University
- Vol. 25 (1) , 79-84
Errors in the diagnosing angioedema on the example of a clinical case
Angioedema is characterized by an acute body reaction to allergens, medications, or other factors, and is a rapidly developing swelling of the skin and mucous membranes, with a predominant location in tissues with loose subcutaneous fat. The difficulty of making a reliable diagnosis lies in the similarity of clinical symptoms with other diseases and the unavailability of specific laboratory tests in institutions of the general medical network that can confirm angioedema. This article presents the analysis of a clinical case of a primary misdiagnosed angioedema in a 74-year-old woman. This patient had dense edema that filled the entire sublingual area and was not arrested by glucocorticosteroids. Antiseptic and antibacterial therapy led to the relief of edema and a decrease in subjective symptoms, which was the basis for the withdrawal of the primary diagnosis and the final diagnosis of “Infectious and allergic edema of unknown origin.” The difficulties of diagnosis in this clinical case emphasize the importance of a thorough examination and individual management of each patient in order to ensure the correct diagnosis and reduce the likelihood of errors in it.
- 16 February 2026
- Published by Vitebsk State Medical University in Vestnik of Vitebsk State Medical University
- Vol. 25 (1) , 79-84
Open AccessErrors in the diagnosing angioedema on the example of a clinical case
Angioedema is characterized by an acute body reaction to allergens, medications, or other factors, and is a rapidly developing swelling of the skin and mucous membranes, with a predominant location in tissues with loose subcutaneous fat. The difficulty of making a reliable diagnosis lies in the similarity of clinical symptoms with other diseases and the unavailability of specific laboratory tests in institutions of the general medical network that can confirm angioedema. This article presents the analysis of a clinical case of a primary misdiagnosed angioedema in a 74-year-old woman. This patient had dense edema that filled the entire sublingual area and was not arrested by glucocorticosteroids. Antiseptic and antibacterial therapy led to the relief of edema and a decrease in subjective symptoms, which was the basis for the withdrawal of the primary diagnosis and the final diagnosis of “Infectious and allergic edema of unknown origin.” The difficulties of diagnosis in this clinical case emphasize the importance of a thorough examination and individual management of each patient in order to ensure the correct diagnosis and reduce the likelihood of errors in it.
- Open Access
- 23 June 2025
- Published by National Research Mordovia State University MRSU in Medicine and Biotechnology
- Vol. 1 (2) , 177-185
Evaluation of the Effectiveness of Benralizumab in a Patient with Severe Bronchial Asthma
Introduction. Severe bronchial asthma is a form of bronchial asthma that is difficult to treat, characterized by the uncontrollability of symptoms despite strict adherence to therapy and treatment of comorbidities. It may worsen with a reduction in high doses of glucocorticosteroids. The majority of patients with this pathology exhibit the eosinophilic phenotype, which is distinguished by a pronounced severity of the disease, a high frequency of exacerbations, and reduced effectiveness to standard anti-inflammatory therapy. Suppression of eosinophil activity represents a promising direction for the pathogenetic therapy of severe bronchial asthma. In recent decades, active research has focused on the study of gene-engineered biological drugs, which have proven their efficacy. The aim of the study is to evaluate the effectiveness of gene-engineered biological therapy, using the example of benralizumab administration in a patient suffering from severe bronchial asthma and chronic polypoid rhinosinusitis. Materials and methods. The article presents a clinical case of a 55-year-old female patient, A., diagnosed with “Bronchial asthma, non-allergic, severe course. Stage 1 chronic polypous rhinosinusitis”. The investigation utilized clinical, laboratory, and instrumental methods, as well as consultations with specialists. Results. In patient A., prolonged therapy with the 5th treatment stage did not achieve complete disease control. The gene-engineered biological therapy, using benralizumab 30 mg subcutaneously once every 3 weeks (for the first 3 doses), followed by 30 mg subcutaneously once every 4 weeks, demonstrated positive dynamics: stabilization of the patient's condition, a reduction in the frequency of exacerbations and nocturnal asthma attacks, a decrease in the need for hospitalization, and normalization of laboratory and instrumental parameters. Discussion and conclusion. The presented clinical case emphasizes the importance of studying and incorporating new genetically engineered biological agents into medical practice. The article will be of interest to physicians, as the use of modern treatment methods will allow for better disease prognosis and improve patients’ quality of life.
- 23 June 2025
- Published by National Research Mordovia State University MRSU in Medicine and Biotechnology
- Vol. 1 (2) , 177-185
Open AccessEvaluation of the Effectiveness of Benralizumab in a Patient with Severe Bronchial Asthma
Introduction. Severe bronchial asthma is a form of bronchial asthma that is difficult to treat, characterized by the uncontrollability of symptoms despite strict adherence to therapy and treatment of comorbidities. It may worsen with a reduction in high doses of glucocorticosteroids. The majority of patients with this pathology exhibit the eosinophilic phenotype, which is distinguished by a pronounced severity of the disease, a high frequency of exacerbations, and reduced effectiveness to standard anti-inflammatory therapy. Suppression of eosinophil activity represents a promising direction for the pathogenetic therapy of severe bronchial asthma. In recent decades, active research has focused on the study of gene-engineered biological drugs, which have proven their efficacy. The aim of the study is to evaluate the effectiveness of gene-engineered biological therapy, using the example of benralizumab administration in a patient suffering from severe bronchial asthma and chronic polypoid rhinosinusitis. Materials and methods. The article presents a clinical case of a 55-year-old female patient, A., diagnosed with “Bronchial asthma, non-allergic, severe course. Stage 1 chronic polypous rhinosinusitis”. The investigation utilized clinical, laboratory, and instrumental methods, as well as consultations with specialists. Results. In patient A., prolonged therapy with the 5th treatment stage did not achieve complete disease control. The gene-engineered biological therapy, using benralizumab 30 mg subcutaneously once every 3 weeks (for the first 3 doses), followed by 30 mg subcutaneously once every 4 weeks, demonstrated positive dynamics: stabilization of the patient's condition, a reduction in the frequency of exacerbations and nocturnal asthma attacks, a decrease in the need for hospitalization, and normalization of laboratory and instrumental parameters. Discussion and conclusion. The presented clinical case emphasizes the importance of studying and incorporating new genetically engineered biological agents into medical practice. The article will be of interest to physicians, as the use of modern treatment methods will allow for better disease prognosis and improve patients’ quality of life.
- Open Access
- 12 January 2025
- Published by National Research Mordovia State University MRSU in Ogarev-online
- Vol. 13 (1) , 81-87
Characteristics of Drug-Induced Urticaria Based on Data of the Allergology and Immunology Department of the Mordovia Republic Clinical Hospital
Introduction. Medicinal urticaria is an immune-mediated disease characterized by the appearance of itchy rashes that occur in response to medication. The number of reported cases of drug allergies is increasing every year, which makes the study of this topic particularly relevant. The aim of the study is to analyze the characteristics of medicinal urticaria in patients of the Allergology and Immunology Department of the Mordovia Republic Central Clinical Hospital for the period 2022–2024. Materials and Methods. The study presents an analysis of 60 medical records of patients of the Allergology and Immunology Department of the Mordovia Republic Central Clinical Hospital diagnosed with medicinal urticarial for the period 2022–2024. Results. When analyzing the structure of patients, it was found that women aged 31 to 59 years with concomitant cardiovascular diseases and lesions of the gastrointestinal tract are most often ill. The advantage of the group of antibiotics in the structure of causally significant drugs of medicinal urticaria, as well as nonsteroidal anti-inflammatory drugs, angiotensin converting enzyme inhibitors and sartans has been revealed. Discussion and Conclusion. The materials of the article can be useful in formulating recommendations for the safe prescription of medications and raising awareness among medical professionals about possible allergic reactions. This, in turn, will help prevent the occurrence of medicinal urticaria and improve the quality of life of patients.
- 12 January 2025
- Published by National Research Mordovia State University MRSU in Ogarev-online
- Vol. 13 (1) , 81-87
Open AccessCharacteristics of Drug-Induced Urticaria Based on Data of the Allergology and Immunology Department of the Mordovia Republic Clinical Hospital
Introduction. Medicinal urticaria is an immune-mediated disease characterized by the appearance of itchy rashes that occur in response to medication. The number of reported cases of drug allergies is increasing every year, which makes the study of this topic particularly relevant. The aim of the study is to analyze the characteristics of medicinal urticaria in patients of the Allergology and Immunology Department of the Mordovia Republic Central Clinical Hospital for the period 2022–2024. Materials and Methods. The study presents an analysis of 60 medical records of patients of the Allergology and Immunology Department of the Mordovia Republic Central Clinical Hospital diagnosed with medicinal urticarial for the period 2022–2024. Results. When analyzing the structure of patients, it was found that women aged 31 to 59 years with concomitant cardiovascular diseases and lesions of the gastrointestinal tract are most often ill. The advantage of the group of antibiotics in the structure of causally significant drugs of medicinal urticaria, as well as nonsteroidal anti-inflammatory drugs, angiotensin converting enzyme inhibitors and sartans has been revealed. Discussion and Conclusion. The materials of the article can be useful in formulating recommendations for the safe prescription of medications and raising awareness among medical professionals about possible allergic reactions. This, in turn, will help prevent the occurrence of medicinal urticaria and improve the quality of life of patients.
- Open Access
- 29 December 2021
- Published by Silicea - Poligraf, LLC in Аcademy of Medicine and Sports
- Vol. 2 (3) , 13-16
Medicine and athletics evolution
The article discusses the most popular type of Olympic movement — athletics. All stages of athletics formation and development are highlighted and described.A connection from ancient athleticism to modern Olympism is described, including the problem of globalization of sports and medical supervision.From the very beginning, athletics has established itself as an international sport in which men and women from all over the world participate.New trends of the late XX — early XXI century have a serious impact on various areas of modern life, including the sports industry and the Olympic movement.The communication revolution has brought not only benefits, but also created new problems. Based on the study of athletics development, it has been established that the Olympic movement remains an important international institution working to strengthen mutual understanding and cooperation between peoples.Further, the International Olympic Committee notes the expansion of educational work to spread the Olympic values and ideals of sport.The article is devoted to topical issues of the Olympic movement, which have a significant impact on social processes.
- 29 December 2021
- Published by Silicea - Poligraf, LLC in Аcademy of Medicine and Sports
- Vol. 2 (3) , 13-16
Open AccessMedicine and athletics evolution
The article discusses the most popular type of Olympic movement — athletics. All stages of athletics formation and development are highlighted and described.A connection from ancient athleticism to modern Olympism is described, including the problem of globalization of sports and medical supervision.From the very beginning, athletics has established itself as an international sport in which men and women from all over the world participate.New trends of the late XX — early XXI century have a serious impact on various areas of modern life, including the sports industry and the Olympic movement.The communication revolution has brought not only benefits, but also created new problems. Based on the study of athletics development, it has been established that the Olympic movement remains an important international institution working to strengthen mutual understanding and cooperation between peoples.Further, the International Olympic Committee notes the expansion of educational work to spread the Olympic values and ideals of sport.The article is devoted to topical issues of the Olympic movement, which have a significant impact on social processes.